Variant report
Variant | nsv614860 |
---|---|
Chromosome Location | chr9:94396059-94399244 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 2)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | EGR1 | chr9:94397213-94397358 | K562 | blood: | n/a | n/a |
2 | FOXA1 | chr9:94395941-94396158 | T-47D | breast: | n/a | n/a |
3 | ZNF263 | chr9:94397202-94397470 | HEK293-T-REx | kidney: | n/a | chr9:94397353-94397374 |
No data |
No data |
No data |
miRNA name | Chromosome Location | mirBase accession |
---|---|---|
hsa-miR-3910 | chr9:94398559-94398578 | MIMAT0018184_1 |
hsa-miR-3910 | chr9:94398595-94398614 | MIMAT0018184 |
No data |
Variant related genes | Relation type |
---|---|
MIR3910-2 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1492682 | chr9:94396059-94396060 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs576378253 | chr9:94396068-94396069 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs117526615 | chr9:94396113-94396114 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs1492683 | chr9:94396124-94396125 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs7855529 | chr9:94396138-94396139 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs185467857 | chr9:94396149-94396150 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs534723395 | chr9:94396156-94396157 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs552943372 | chr9:94396157-94396158 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs543059934 | chr9:94396299-94396300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190274946 | chr9:94396309-94396310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs151064995 | chr9:94396315-94396316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557556072 | chr9:94396363-94396364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7852614 | chr9:94396366-94396367 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs72744411 | chr9:94396367-94396368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375895339 | chr9:94396374-94396375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540011348 | chr9:94396387-94396388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558519756 | chr9:94396404-94396405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113366928 | chr9:94396426-94396427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139129111 | chr9:94396458-94396459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541067875 | chr9:94396483-94396484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs9696915 | chr9:94396484-94396485 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs182521833 | chr9:94396492-94396493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs541531966 | chr9:94396494-94396495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs74893506 | chr9:94396499-94396500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10992021 | chr9:94396561-94396562 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs115942273 | chr9:94396583-94396584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564084107 | chr9:94396593-94396594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116856620 | chr9:94396603-94396604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560675040 | chr9:94396641-94396642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs546596793 | chr9:94396656-94396657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369006202 | chr9:94396663-94396664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs568065209 | chr9:94396673-94396674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187752022 | chr9:94396675-94396676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs10992022 | chr9:94396676-94396677 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs190833989 | chr9:94396710-94396711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571482527 | chr9:94396713-94396714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368015467 | chr9:94396737-94396738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs539692603 | chr9:94396745-94396746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558374371 | chr9:94396772-94396773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573590211 | chr9:94396775-94396776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs371837410 | chr9:94396861-94396862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs58483310 | chr9:94396881-94396882 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs553025928 | chr9:94396893-94396894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs62565052 | chr9:94396934-94396935 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs541794199 | chr9:94396945-94396946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs62565053 | chr9:94396981-94396982 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs574217962 | chr9:94397206-94397207 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs536720852 | chr9:94397209-94397210 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs373294800 | chr9:94397210-94397211 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs71362345 | chr9:94397211-94397212 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Biliary cancer | 19435499 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Mental retardation | 21693067 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell nevus syndrome | 21572526 | CNVD |
Mental retardation | 19951919 | CNVD |
Retinoblastoma | 22278416 | CNVD |
9q22.3 microdeletion syndrome | 22283845 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:94395600-94397000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |